Olema Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.89-$36.25 |
Market Cap | $1.3B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.85 |
News
See moreYahoo Finance • 22 days ago
Jim Cramer on Olema Pharmaceuticals: “Too Risky for Me”
Yahoo Finance • 24 days ago
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?
Yahoo Finance • 29 days ago
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Yahoo Finance • 30 days ago
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
About
CEO | Dr. Sean P. Bohen M.D., Ph.D. |
Address | 780 Brannan Street, San Francisco, CA, United States, 94103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 131 |
